| Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis | |
| Luo, Xuan; Deng, Chuiwen; Fei, Yunyun; Zhang, Wen; Li, Yongzhe; Zhang, Xuan; Zhao, Yan; Zeng, Xiaofeng; Zhang, Fengchun | |
| 2019 | |
| 卷号 | 48期号:4页码:626-631 |
| 关键词 | Psoriatic arthritis Cancer risk Conventional synthetic disease modifying antirheumatic drugs Risk factor Meta-analysis |
| ISSN号 | 0049-0172 |
| DOI | 10.1016/j.semarthrit.2018.05.009 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6346330 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Luo, Xuan,Deng, Chuiwen,Fei, Yunyun,et al. Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis[J],2019,48(4):626-631. |
| APA | Luo, Xuan.,Deng, Chuiwen.,Fei, Yunyun.,Zhang, Wen.,Li, Yongzhe.,...&Zhang, Fengchun.(2019).Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis.,48(4),626-631. |
| MLA | Luo, Xuan,et al."Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis".48.4(2019):626-631. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论